E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/18/2018 in the Prospect News Structured Products Daily.

JPMorgan plans 6.8% contingent interest autocallables tied to AbbVie

New York, June 18 – JPMorgan Chase Financial Co. LLC plans to price 6.8% autocallable contingent interest notes due Sept. 30, 2019 linked to the common stock of Abbvie Inc. stock, according to a 424B2 filed with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annual rate of 6.8% if the stock closes at or above the 65% interest barrier on the review date for that quarter.

The notes will be called at par plus the contingent coupon if the shares close at or above the initial price on a quarterly review date other than the first and final dates.

The payout at maturity will be par plus unless the stock closes below its 65% trigger level on any day during the life of the notes, in which case investors will be fully exposed to any losses.

The notes are guaranteed by JPMorgan Chase & Co.

J.P. Morgan Securities LLC is the underwriter.

The notes will price on June 29 and settle on July 5.

The Cusip number is 48129M3G9.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.